These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 524148)

  • 1. Factor VIII inhibitors, natural history and management.
    Allain JP
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):241-2. PubMed ID: 524148
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII inhibitors in hemophilia.
    Mariani G
    Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)].
    Fukutake K; Fujimari M; Ukita M; Kitahara T
    Rinsho Ketsueki; 1973 Dec; 14(0):1393-99. PubMed ID: 4807613
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of anti-factor VIII antibodies.
    Blatt PM; White GC; McMillan CW; Roberts HR
    Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L
    ASDC J Dent Child; 1979; 46(1):54-6. PubMed ID: 283081
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibitors against factor VIII in hemophilia. A review of treatment possibilities and personal results].
    Scheibel E; Feddersen C
    Ugeskr Laeger; 1985 Nov; 147(47):3803-7. PubMed ID: 3934824
    [No Abstract]   [Full Text] [Related]  

  • 9. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM; Ménaché D; Roberts HR
    Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K; Nowotny C; Krinninger B; Zegner M; Deutsch E
    Thromb Haemost; 1979 Feb; 40(3):478-85. PubMed ID: 425062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A; Roisenberg I
    Thromb Haemost; 1999 Mar; 81(3):475-6. PubMed ID: 10102489
    [No Abstract]   [Full Text] [Related]  

  • 12. Postpartum acquired factor VIII inhibitors.
    Franchini M
    Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII inhibitors.
    Gilles JG; Jacquemin MG; Saint-Remy JM
    Thromb Haemost; 1997 Jul; 78(1):641-6. PubMed ID: 9198231
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized study of factor VIII or prothrombin complex concentrate infusions in children with haemophilia and antibodies to factor VIII.
    Ekert H; Price DA; Lane JL; Dean FL
    Aust N Z J Med; 1979 Jun; 9(3):241-4. PubMed ID: 288389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
    Verbruggen B; Novakova I; Wessels H; Boezeman J; van den Berg M; Mauser-Bunschoten E
    Thromb Haemost; 1995 Feb; 73(2):247-51. PubMed ID: 7792738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
    Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
    Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hemophilia patients with inhibitors.
    Hedner U; Glazer S
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1035-46. PubMed ID: 1400071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suggestions for the management of factor VIII inhibitors.
    Rubinger M; Rivard GE; Teitel J; Walker H;
    Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Yee TT; Lee CA
    Thromb Haemost; 1999 May; 81(5):852. PubMed ID: 10365768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.